Enzymatica AB: Enzymatica - publication of the annual report 2016

Press release
Lund, 6 April, 2017
                                                                                   

Enzymatica - publication of the annual report 2016

Enzymatica announces today that the annual report 2016 is available on the company's web site
www.enzymatica.se. The annual report is produced in Swedish. A brief English version of the annual report is available on the English version of the website.

For more information, please contact:

Fredrik Lindberg, CEO Enzymatica AB
Tel: [phone] | E-post: [e-mail]

Jörgen Rexö, VP Legal & Communications Enzymatica
Tel: [phone] | E-post: [e-mail]   

About Enzymatica AB
Enzymatica is a life science company who develops and sells medical device products against infectious-related diseases. Over a short period the company has developed a unique oral spray for colds, ColdZyme®, and launched it on eight markets. The product has become one of the leading articles for colds in Swedish pharmacies. Enzymatica's strategy is to continue growing by strengthening its position in existing markets and to expand to more geographical markets through well-established partners. The company is headquartered in Lund, Sweden and is listed on Nasdaq First North. For more information, please visit www.enzymatica.com.   

Enzymatica's certified advisor is Erik Penser Bankaktiebolag.

PR Enzymatica releases annual report 2016

---

This announcement is distributed by Nasdaq Corporate Solutions on behalf of Nasdaq Corporate Solutions clients.
The issuer of this announcement warrants that they are solely responsible for the content, accuracy and originality of the information contained therein.
Source: Enzymatica AB via Globenewswire